Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

70.13
BATS BZX Real-Time Price
As of 10:49am ET
 -0.56 / -0.79%
Today’s Change
69.78
Today|||52-Week Range
103.10
-2.07%
Year-to-Date
3 Biotech Stocks to Buy and Hold Stress-Free
8:15am / MotleyFool.com - Paid Partner Content
Can Q4 Earnings Revitalize Healthcare ETFs?
Jan 23 / Zacks.com - Paid Partner Content
HealthInvest Partners AB Buys Gilead Sciences Inc, McKesson Corp, Syneron Medical Ltd...
7:40am / GuruFocus News - Paid Partner Content
Stock Market News for January 23, 2017
Jan 23 / Zacks.com - Paid Partner Content
Biotech Lags Again, IBB Closes Down Nearly 1% To Trail All ETFs
7:25am / Investing Channel - Paid Partner Content
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Jan 23 / MotleyFool.com - Paid Partner Content
Gilead (GILD) HCV Therapy Application Validated in Europe
Jan 23 / Zacks.com - Paid Partner Content
How Will Gilead Sciences Fare Under President Trump?
Jan 22 / MotleyFool.com - Paid Partner Content
Wendell David Associates Inc Buys CDK Global Inc, Dentsply Sirona Inc, Alphabet Inc, ...
Jan 23 / GuruFocus News - Paid Partner Content
3 Incredibly Cheap High-Yield Dividend Stocks
Jan 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close70.69
Today’s open70.58
Day’s range69.78 - 70.99
Volume190,992
Average volume (3 months)9,689,739
Market cap$93.1B
Dividend yield2.68%
Data as of 10:49am ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-9.26%
Earnings growth (next 5 years)-0.55%
Revenue growth (last year)+28.71%
P/E ratio6.5
Price/Sales4.80
Price/Book5.42

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.80-1.18%
BIIBBiogen-2.04-0.74%
ILMNIllumina Inc-1.71-1.06%
ARIAARIAD Pharmaceutical...+0.03+0.13%
Data as of 10:49am ET, 01/24/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$2.61
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs